Your Patient Needs Ertaczo — Now What?

You've prescribed Ertaczo (Sertaconazole Nitrate) 2% cream for a patient with a stubborn dermatophyte infection, and you know it's the right choice. But your patient calls back: their pharmacy doesn't have it, the next pharmacy quoted them over $1,000, and they're frustrated.

This scenario plays out regularly. Ertaczo's brand-only status, limited distribution, and high cost create access barriers that affect both patients and the practices that prescribe it. This guide provides actionable steps your practice can take to help patients find and afford Ertaczo.

Current Availability Landscape

Ertaczo is not in a formal FDA-declared shortage, but real-world access is limited by several factors:

• No generic: Sertaconazole has no generic equivalent in the U.S., meaning Ertaczo is the only option.
• Retail price: $897-$1,070 per tube discourages pharmacy stocking.
• Single manufacturer: DPT Laboratories (San Antonio, TX) is the sole producer, distributed by Coral Way Pharma.
• Payer restrictions: Most plans require prior authorization or step therapy.

For a detailed supply analysis, see our Ertaczo provider shortage briefing.

Why Your Patients Can't Find It

Understanding the barriers helps your staff address them proactively:

Pharmacy Stocking Decisions

Chain pharmacies make stocking decisions based on demand forecasting. With Ertaczo's high cost and low fill volume, many locations don't carry it. The medication isn't sitting in a back room somewhere — it's simply not ordered unless there's a confirmed prescription.

Insurance Denials and Delays

Even when a pharmacy can obtain Ertaczo, insurance barriers may prevent the patient from picking it up. Common scenarios include:

• Prior authorization required but not yet submitted
• Step therapy requirement — patient must try OTC Clotrimazole or Terbinafine first
• Non-formulary status — plan doesn't cover it at all
• High specialty-tier copay ($100+) that the patient wasn't expecting

Patient Sticker Shock

When patients learn the cash price exceeds $1,000, many abandon the prescription entirely rather than exploring discount options. This contributes to the cycle of low demand and limited stocking.

What Your Practice Can Do: 5 Steps

Step 1: Verify Stock Before the Patient Leaves

The most impactful thing you can do is check pharmacy availability before the patient leaves your office. Use Medfinder for Providers to check real-time stock at pharmacies near the patient's home or workplace. This takes less than a minute and prevents the frustration of rejected fills.

Consider making this part of your standard workflow for brand-only medications: prescribe → check stock → send the prescription to a confirmed location.

Step 2: Submit Prior Authorization Proactively

Don't wait for the pharmacy to trigger the PA process. If you know the patient's plan requires prior authorization, submit it before or at the time of prescribing. Include:

• Documentation of previously tried OTC antifungals and outcomes
• Clinical rationale for Sertaconazole (dual MOA, anti-inflammatory properties, treatment-resistant dermatophytosis)
• Infection severity, duration, and impact on quality of life

Proactive PA submission can save 3-7 days of wait time and reduce the chance the patient gives up on the prescription.

Step 3: Direct Patients to Independent Pharmacies

Independent pharmacies typically have more flexibility to source niche medications. They often work with multiple wholesalers and are more willing to special-order Ertaczo for individual patients. Build a relationship with one or two independent pharmacies in your area that reliably handle brand-only medications.

Step 4: Arm Patients With Cost-Saving Resources

Before the patient leaves, let them know about discount options:

• SaveHealth card: Can reduce cost to approximately $447
• GoodRx coupon: Can reduce cost to approximately $897
• SingleCare: Additional discount option
• NeedyMeds and RxAssist: For patients with financial hardship

Direct patients to our comprehensive Ertaczo savings guide and our provider savings guide for additional strategies.

Step 5: Have an Alternative Ready

When you prescribe Ertaczo, always have a backup plan in mind. Tell the patient: "I'm prescribing Ertaczo because it's the best fit for your condition. If you have trouble finding it or affording it, here's what we'll try next." This sets expectations and prevents patients from going untreated if Ertaczo proves inaccessible.

Alternative Agents

When Ertaczo isn't feasible, consider these alternatives based on the clinical scenario:

For Uncomplicated Tinea Pedis

• Terbinafine (Lamisil) OTC: $8-$15. Fungicidal allylamine. Excellent first-line option for most patients.
• Clotrimazole (Lotrimin) OTC: $8-$15. Same azole class as Ertaczo but without the dual mechanism.

For Treatment-Resistant or Inflammatory Tinea

• Naftifine (generic Naftin): $30-$80 with discount card. Allylamine with anti-inflammatory properties similar to Ertaczo. Generic availability improves access.
• Luliconazole (Luzu): $500-$800. Newer azole with potent dermatophyte activity and once-daily dosing. Also brand-only, similar access challenges.

For Severe or Extensive Disease

• Consider oral Terbinafine or Itraconazole with appropriate monitoring (LFTs, drug interaction check).

A comprehensive patient-facing comparison is available at Ertaczo alternatives.

Workflow Tips for Your Practice

• Maintain a "hard-to-find" medication list: Flag brand-only medications like Ertaczo in your EHR so staff knows to verify stock before prescribing.
• Bookmark Medfinder: Add medfinder.com/providers to your EHR bookmarks bar for quick access during prescribing.
• Create PA templates: Pre-populate prior authorization forms for medications you prescribe regularly. This reduces turnaround time.
• Educate front office staff: Train medical assistants and prescription coordinators on the availability challenges for brand-only medications so they can manage patient expectations.
• Follow up: Check with patients at their next visit (or via a quick call/message) to confirm they were able to fill the prescription and start treatment on time.

Final Thoughts

Ertaczo is a clinically valuable antifungal with a unique mechanism of action, but prescribing it requires more than just writing the script. The combination of brand-only status, high cost, and limited pharmacy stocking means your practice plays a critical role in helping patients actually access the medication.

By integrating stock verification, proactive prior authorization, cost-saving resources, and alternative planning into your workflow, you can minimize treatment delays and ensure your patients with fungal infections get the care they need.

Start using Medfinder for Providers today to make the prescribing process smoother for your team and your patients.